What is methocarbamol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Methocarbamol?

Methocarbamol is a centrally acting skeletal muscle relaxant and sedative available in both oral and intravenous formulations, used as an adjunct to rest and physical therapy for acute, painful musculoskeletal conditions. 1

Mechanism of Action

The precise mechanism of action remains unclear, but methocarbamol does not directly relax tense skeletal muscles 2. Its therapeutic effects are likely related to its sedative properties and central nervous system (CNS) depressant activity 1.

Chemical Structure

Methocarbamol is a carbamate derivative of guaifenesin with the chemical name 3-(2-methoxyphenoxy)-1,2-propanediol 1-carbamate (molecular formula C₁₁H₁₅NO₅, molecular weight 241.24) 1. It appears as a white powder, sparingly soluble in water and chloroform 1.

Formulations and Dosing

  • Oral tablets: Available in 500 mg and 750 mg strengths 1
  • Intravenous: Contains polyethylene glycol (PEG) 300 and propylene glycol as excipients 3

Adverse Effects Profile

Central Nervous System

  • Drowsiness and dizziness are the most common side effects 2
  • Acts as a CNS depressant with sedative properties 1

Cardiovascular

  • Bradycardia and hypotension can occur, particularly with IV administration 2

Drug Interactions

  • Critical interaction with alcohol: Fatal CNS depression can occur when combined with ethanol due to additive sedative-hypnotic effects 4
  • Interferes with pyridostigmine bromide: Should not be used in patients with myasthenia gravis 2

Special Populations and Contraindications

Renal and Hepatic Impairment

Methocarbamol elimination is significantly impaired in patients with liver and kidney disease 2. Dose adjustments or alternative agents should be considered in these populations.

Absolute Contraindication

  • Myasthenia gravis due to interference with pyridostigmine bromide effects 2

Perioperative Management

According to the 2021 SPAQI consensus guidelines, methocarbamol should be held on the day of surgical procedures 2. Despite one single-center study showing potential benefits in postoperative opioid consumption and recovery metrics after arthroplasty 2, the consensus recommendation prioritizes avoiding potential cardiovascular complications (bradycardia, hypotension) during anesthesia.

Abuse Potential

Unlike other muscle relaxants such as carisoprodol, methocarbamol demonstrates low likelihood of abuse based on behavioral pharmacology studies showing it does not maintain self-administration behavior and lacks discriminative stimulus effects similar to barbiturates or benzodiazepines 5.

Clinical Considerations

IV Formulation Concerns

The IV formulation contains PEG 300, which has been implicated in metabolic acidosis and nephrotoxicity, though evidence remains controversial 6. To mitigate potential risks, IV methocarbamol is typically limited to 72 consecutive hours followed by a 48-hour drug-free interval, though recent data suggest this may be overly cautious 3.

Anticholinergic Effects

Recent ICU data show anticholinergic adverse effects occur in approximately 10.8% of patients receiving methocarbamol, though these rarely lead to medication discontinuation 7.

Analytical Challenges

Methocarbamol presents significant analytical challenges due to low UV absorptivity, rapid metabolism, and pronounced pH-dependent instability 8, which can complicate therapeutic drug monitoring when needed.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.